Brief: ProKidney Announces Publication Of Trial Design For Clinical Trial
10/01/2023 21:14
Jan 10 (Reuters) - ProKidney Corp PROK.O :
* PROKIDNEY ANNOUNCES PUBLICATION OF TRIAL DESIGN FOR PHASE
2
MULTICENTER CLINICAL TRIAL OF REACT FOR LATE STAGE 4
DIABETES-RELATED CHRONIC KIDNEY DISEASE
Source text for Eikon: ID:nGNX6MvGp8
Further company coverage: PROK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prokidney
See all newsProkidney Corp reports results for the quarter ended September 30 - Earnings Summary
ProKidney Q3 loss widens on higher R&D costs
Brief: ProKidney Q3 Operating Income USD -53.758 Million
Brief: Prokidney Corp Enters Open Market Sale Agreement With Jefferies
Cell therapy developer ProKidney's Q2 operating loss widens as trial costs rise